The American Medical Association is warning that the Obama administration could violate physicians' privacy rights if it poorly implements its new policy for informing the public how much money Medicare pays to individual doctors. But other groups say the administration did not go far enough in making payment data broadly accessible.
The American Medical Association is warning that the Obama administration could violate physicians' privacy rights if it poorly implements its new policy for informing the public how much money Medicare pays to individual doctors. But other groups say the administration did not go far enough in making payment data broadly accessible.
On Tuesday, HHS announced that it would begin responding to Freedom of Information Act requests for physician-payment data. The agency didn't guarantee every request would be filled, but said government officials would begin using a “balancing test” to determine which information should be released.
FOIA's privacy exemption may still shield some information from public view if the damage to physician privacy is judged greater than the public interest in the information. In no case would such disclosures reveal the identities of individual patients, the agency said. “As the outcome of the balancing test will depend on the circumstances, the outcomes of these analyses may vary depending on the facts of each case,” HHS said in the rule. “However, in all cases, we are committed to protecting the privacy of Medicare beneficiaries.”
Read the full story here: http://bit.ly/1iUunAi
Source: Modern Healthcare
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More